PatentsGlobal
Alto Neuroscience Secures New U.S. Patent for ALTO-207 Method of Treatment in Depression
Alto Neuroscience has bolstered its intellectual property portfolio with the grant of a new U.S. patent covering a method of treatment using ALTO-207 for depression. This development underscores the company’s commitment to advancing innovative therapeutic approaches in mental health and protecting its proprietary tech…
Thursday, May 14, 2026